Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At-home blood pressure monitoring using a web-based system offering personalised support and linked to a remote healthcare professional can result in better hypertension management than face-to-face consultations, finds a study led by University of Oxford, Bristol and Southampton researchers.

A lady measuring her blood pressure at home using a cuff, and a laptop. © Shutterstock
At a time when many people are unfortunately unable to visit their GP in person, this digital and remote approach could provide a simple way for GPs to effectively manage hypertension in many members of their community, reducing their need to visit the practice for regular check-ups.
- Professor Richard McManus, University of Oxford

In the United Kingdom, more than 30 percent of adults have raised blood pressure, also known as hypertension, which is a major risk factor for cardiovascular disease internationally. With GP surgeries currently requesting that many patients opt for virtual consultations to avoid exposure to coronavirus infection, the clinical monitoring of hypertensive patients using face-to-face consultation is a challenge for primary care.

The Home and Online Management and Evaluation of Blood Pressure (HOME BP) randomised controlled trial evaluated the combination of regular self-monitoring at home with a web-based tool that offered reminders, predetermined drug changes, lifestyle advice and motivational support.

In their paper, published today in the BMJ, the researchers report that for participants managing their blood pressure at home, mean systolic blood pressure was significantly lower after 12 months compared with those managed exclusively in the clinic, giving a mean difference of -3.4mm Hg between groups. Those who were self-monitoring at home were also more likely to have their treatment adjusted by their healthcare professional. The approach was not expensive, at £11 per mm Hg reduction in blood pressure.

622 participants aged 18 or over with hypertension were recruited into the trial from 76 general practices across the UK, with half assigned to managing their blood pressure at home. The trial was funded by the National Institute for Health Research.

HOME BP trial lead, Professor Richard McManus, a GP and Professor of Primary Care at the University of Oxford’s Nuffield Department of Primary Care Health Sciences, said, ‘We already know from research that when patients self-monitor and manage their blood pressure they typically have better control of their hypertension. Yet these systems often rely on relatively expensive technology, complex instructions and/or time-consuming training. We combined self-monitoring with an easy-to-use and inexpensive digital tool that provides feedback to the patient and their clinician and aims to support healthy behaviours. Our trial found this can lead to lower blood pressure at low additional cost compared to usual, face-to-face care.

‘At a time when many people are unfortunately unable to visit their GP in person, this digital and remote approach could provide a simple way for GPs to effectively manage hypertension in many members of their community, reducing their need to visit the practice for regular check-ups.’

Professor Lucy Yardley, from the School of Psychological Science at the University of Bristol and the School of Psychology at the University of Southampton, said: ‘Our findings are especially important now that the coronavirus pandemic has made it urgent and vital to be able to offer remote, high-quality care to patients with high blood pressure. The HOME BP trial was developed with extensive feedback from people with high blood pressure and primary care staff to ensure that patients and clinicians found it helpful and trustworthy.’

Professor Paul Little, Professor of Primary Care Research within Medicine at the University of Southampton, said: ‘Given the trial results, if this approach was implemented at scale then we would expect it to result in a reduction of 10 to 15 per cent in patients having a stroke and a reduction of five to 10 per cent in patients experiencing coronary events. With a low marginal cost, this could make a major difference to the millions of people being treated for hypertension in the UK and worldwide.’

Cathy Rice, a stroke survivor who contributed to the development of the HOME BP trial, said: ‘I was amazed when I first heard how many people in the UK don’t have their blood pressure well controlled. It’s very satisfying that this project was so successful at working with patients to measure their own blood pressure and reduce it.’

As well as enabling a patient’s GP to adjust drug treatment based on regular blood pressure readings, the HOME BP system offered evidence-based tips on diet and weight-loss, exercise, salt and alcohol reduction. One-to-one behavioural support was also made available through practice nurses and healthcare assistants.

At least 30 to 40 percent of people with hypertension already check their own blood pressure but many do not mention this to their GP or nurse. Accurate monitors can be purchased for around £20 and have a useful life of around five years. This study suggests that current efforts to encourage people to self-monitor could reap real dividends for both the NHS and people with high blood pressure.

While the study found this digital approach to managing hypertension was beneficial overall, for participants aged 67 or over the reduction in blood pressure compared with usual care was found to be less pronounced than in those aged under 67. This was unexpected and at odds with similar research in this area, and the researchers say that further work is needed to understand whether this is a real effect.

Read more

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial

Richard J McManus, Paul Little, Beth Stuart et al
BMJ 2021; 372:m4858 doi: 10.1136/bmj.m4858